Procyrion Raises $16 Million Series C for Clinical Trials of Its Breakthrough Aortix Heart Pump Houston, TX (January 30, 2018) – Procyrion, Inc., a clinical-stage medical device company, today announced the completion of a $16 million Series C funding round led by an affiliate of Fannin Partners. Returning investors include […]



